Predictive cytokine biomarkers for immune-related adverse events associated with immune checkpoint inhibitor therapy in Hodgkin lymphoma. Biomarkers Specificity (95% CI) Positive Likelihood Ratio (95% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results